Search results
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
Associated Press via Yahoo News· 1 day agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 3 days agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
Halozyme Therapeutics (HALO) Up 8.7% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 16 hours agoPerformance of an Industry Player Halozyme Therapeutics belongs to the Zacks Medical - Biomedical...
FDA approves Moderna's RSV shot for older adults
Becker’s Hospital Review· 4 days agoThe FDA has given the green light to Moderna's mRNA-based respiratory syncytial virus vaccine, specifically for older adults, the drugmaker announced May 31. "This approval ...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 2 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...
US approves Moderna’s RSV vaccine for older adults | FOX 28 Spokane
FOX 28 Spokane· 7 days agoThe US Food and Drug Administration on Friday approved Moderna’s respiratory syncytial virus (RSV)...
US approves Moderna's RSV vaccine for older adults
Alaska Superstation· 7 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults -- marking the first time any...
FDA vaccine advisers vote unanimously in favor of updated COVID-19 shot for fall
WBAL-TV Baltimore· 15 hours agoThe Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday to...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 4 days agoInsights from TIME, The Washington Post, MIT Technology Review The News Pharmaceutical giants ...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga· 4 days agoMonday, Moderna Inc MRNA and Merck & Co Inc MRK announced the first presentation of results from a planned analysis from the Phase 2b KEYNOTE-942/mRNA-4157-P201 study. The ...